Johnson & Johnson Considers Sale of Orthopedics Unit

Johnson & Johnson is reportedly considering the sale of its orthopedics division, which it has been planning to separate. Bloomberg posted on X that major buyout firms are already showing interest in the potential sale. The move is part of Johnson & Johnson's strategy to streamline its operations and focus on its core businesses. The orthopedics unit, known for its medical devices and surgical products, could attract significant attention from private equity firms looking to expand their healthcare portfolios. The decision aligns with the company's broader efforts to optimize its business structure and enhance shareholder value.